Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,825
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Location: Salisbury NC, Philadelphia PA, New York NY,
Sponsor: Sun Pharmaceutical Industries Limited
Sex: Male
Age: 18+
Code: NCT05422911
Phase 2, Recruiting
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
for
Relapsed Small Cell Lung Cancer,
Location: Salisbury NC, Pittsburgh PA, Philadelphia PA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06681220
Phase 1, Phase 2, Recruiting
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
for
Carcinoma, Hepatocellular, Cirrhosis
Location: Salisbury NC, Durham NC, Columbia SC, Charleston SC,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT05486572
Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: Durham NC, Lexington KY, Richmond VA, Fairfax VA,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase 2, Phase 3, Recruiting
ERP to Improve Functioning in Veterans With OCD
for
Obsessive Compulsive Disorder (OCD),
Location: Salisbury NC, Durham NC, Salem VA, Fayetteville NC,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05240924
Recruiting
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
for
Duchene Muscular Dystrophy
Location: Durham NC, Washington D.C. DC, New York NY, Chicago IL,
Sponsor: ITF Therapeutics LLC
Sex: All
Age: 6+
Code: NCT07127978
Recruiting
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
for
FSHD
Location: Durham NC, Richmond VA, Baltimore MD, Columbus OH,
Sponsor: University of Kansas Medical Center
Sex: All
Age: 0+
Code: NCT04635891
Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Durham NC, Charlottesville VA, Richmond VA,